Drugs for the treatment of melanoma

Melanoma is one of the most aggressive cancers. The main means of treating the disease are surgery and chemotherapy. However, modern medicine allows for the inclusion of new methods and drugs for the treatment of melanoma in the treatment regimen. These procedures and medications allow for faster treatment and bring the disease into remission.

Targeted therapy

Targeted therapy is a new treatment method aimed at the targeted destruction of cancer cells. The difference between classical and targeted therapy is huge. The drugs used for this type of treatment can recognize mutating cells and destroy them without damaging healthy organs and tissues. Targeted drugs are prescribed to patients in case of detection of mutations in the V600E, V600K and BRAF genes, which are responsible for the division of melanocytes.

Targeted therapy drugs for the treatment of melanoma

Drugs for the treatment of melanoma "Vemurafenib", "Dabrafenib" and "Zelboraf" block the activity of proteins that are produced under the influence of a mutating gene, thereby preventing further tumor growth. Trametinib and Combitenib slow down the development of cancer cells by destroying their connections at the immune level. The drugs Sorafenib and Imatinib do not give effective results in the treatment of melanoma on the skin. However, when the mucous membranes are thinned, they significantly reduce the size of the neoplasm and the risk of metastasis.

Targeted drugs for melanoma are included in the treatment regimen in combination or separately, depending on the type of melanoma and the degree of its spread. The use of targeted drugs in combination with classical methods can reduce the duration of treatment of melanoma and minimize the occurrence of recurrence of the disease.

If the patient's condition or age does not allow surgery to remove the tumor, targeted therapy can reduce the size of the tumor, the severity of symptoms and disease, and prolong life.

Currently, a wide range of studies are being conducted on the synthesis of drugs for the treatment of melanoma. Scientists around the world are developing drugs that will achieve remission even in the late stages of the disease with minimal side effects.